J Korean Surg Soc.
1998 Jun;54(Suppl):966-974.
Expression of CD44H in Gastric Cancer Cells and Binding Ability to the
Peritoneal Mesothelium
- Affiliations
-
- 1Departments of Surgery and 1Internal Medicine, Catholic University Medical College.
Abstract
- Understanding of the adhesion molecules involved in the interaction of gastric cancer cells with peritoneal
mesothelial cells (PMC) might provide a useful strategy for interfering with cancer cell implantation
to the peritoneum. Since CD44H is a major cell surface receptor for hyaluronate (HA), it may play
an important role in mediating cancer cell adhesion to PMC through recognition of mesothelium associated HA. The purpose of the present study was to define the functional significance of CD44H
in peritoneal metastasis of gastric cancer cells by using quantitative assays for measuring the adhesion
ability to PMC in vitro. CD44 expression in gastric cancer cell lines SNU-1, -5, and -16 were examined
by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis. CD44H was
expressed in SNU-5 and -16 whereas no significant level of CD44H was expressed in SNU-1. SNU-16
expressed additional high-molecular-weight CD44 isoforms. In the adhesion assay with HA coated
microtiter wells, SNU-5 and -16 demonstrated high affinity for HA, with values of 64.6+/-10.5% and
91.1+/-8.8%, respectively. SNU-1 demonstrated no significant binding affinity for HA (p<0.05). For the
in vitro binding assay, we used a confluent monolayer of PMC. 2.5x10(4) and 5x10(4) gastric cancer
cells labelled with 51 Cr were inoculated into microtiter wells and allowed to adhere for 2 hr. After
washing of the unattached cancer cells, adherent cells were lysed with 0.1 N NaOH and the radioactivity
was measured in the lysates. SNU-5 and -16 bound to PMC, to the extent of 10.0+/-1.0%, 14.6+/-1.8%
and 22.9+/-2.0%, 23.7+/-3.6%, respectively. In contrast, SNU-1 demonstrated lower binding ability(6.4+/-
0.5%, 6.7+/-1.3%, respectively) to PMC. In conclusion, CD44H is at least partly involved in gastric cancer
cell binding to PMC, which mediates an important first step of peritoneal implantation.